One-step synthesis of efficient binding-inhibitor for influenza virus through multiple addition of sialyloligosaccharides on chitosan

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Carbohydrate Polymers

• Publication date

  2010-06-11

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/J.CARBPOL.2010.02.014
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Evolution of three dimensional skin equivalent models reconstructed in vitro by tissue engineering.

  2009cited by this paper
• Chitosan micro- and nanospheres: fabrication and applications for drug and DNA delivery.

  2009cited by this paper
• Genetic engineering of Escherichia coli for the economical production of sialylated oligosaccharides.

  2008cited by this paper
• Design of a sialylglycopolymer with a chitosan backbone having efficient inhibitory activity against influenza virus infection.

  2008cited by this paper
• Influenza virus hemagglutinin--structural studies and their implications for the development of therapeutic approaches.

  2007cited by this paper
• Recent anti-influenza strategies in multivalent sialyloligosaccharides and sialylmimetics approaches.

  2007cited by this paper
• Chemoenzymatic synthesis and application of a sialoglycopolymer with a chitosan backbone as a potent inhibitor of human influenza virus hemagglutination.

  2006cited by this paper
• Sialobiology of influenza: molecular mechanism of host range variation of influenza viruses.

  2005cited by this paper
• BAG-1 in carcinogenesis

  2004cited by this paper
• Chemical Modification of Chitosan, 17

  2003cited by this paper
• Chemoenzymatic synthesis and application of glycopolymers containing multivalent sialyloligosaccharides with a poly(L-glutamic acid) backbone for inhibition of infection by influenza viruses.

  2003cited by this paper
• Chemical modification of chitosan. Part 15: synthesis of novel chitosan derivatives by substitution of hydrophilic amine using N-carboxyethylchitosan ethyl ester as an intermediate.

  2003cited by this paper
• Preparation and Lectin Binding Property of Chitosan–Carbohydrate Conjugates

  2001cited by this paper
• Mechanisms of cell entry by influenza virus

  2001cited by this paper
• Chemical Modification of Chitosan. 10.1 Synthesis of Dendronized Chitosan−Sialic Acid Hybrid Using Convergent Grafting of Preassembled Dendrons Built on Gallic Acid and Tri(ethylene glycol) Backbone

  2001cited by this paper
• Highly Convergent Synthesis of Dendrimerized Chitosan−Sialic Acid Hybrid1

  2001cited by this paper
• Large-scale production of CMP-NeuAc and sialylated oligosaccharides through bacterial coupling

  2000cited by this paper
• Chemical Modification of Chitosan. 3. Hyperbranched Chitosan−Sialic Acid Dendrimer Hybrid with Tetraethylene Glycol Spacer

  2000cited by this paper
• Chemical modification of chitosan: preparation of chitosan–sialic acid branched polysaccharide hybrids

  2000cited by this paper
• Neuraminidase Inhibitors as Anti-Influenza Virus Agents

  1999cited by this paper
• Chemical modification of chitin and chitosan 2: preparation and water soluble property of N-acylated or N-alkylated partially deacetylated chitins

  1999cited by this paper
• Essentials of Glycobiology

  1999cited by this paper
• Changes in H3 influenza A virus receptor specificity during replication in humans.

  1998cited by this paper
• The synthesis of sialylated oligosaccharides using a CMP-Neu5Ac synthetase/sialyltransferase fusion

  1998cited by this paper
• Structure−Activity Relationship Studies of Novel Carbocyclic Influenza Neuraminidase Inhibitors

  1998cited by this paper
• 'Flu' and structure-based drug design.

  1997cited by this paper
• Differences in sialic acid-galactose linkages in the chicken egg amnion and allantois influence human influenza virus receptor specificity and variant selection

  1997cited by this paper
• Occurence of a sialylglycopeptide and free sialylglycans in hen's egg yolk.

  1997cited by this paper
• Polyacrylamides Bearing Pendant α-Sialoside Groups Strongly Inhibit Agglutination of Erythrocytes by Influenza Virus: The Strong Inhibition Reflects Enhanced Binding through Cooperative Polyvalent Interactions

  1996cited by this paper
• Structural determination of gangliosides that bind to influenza A, B, and C viruses by an improved binding assay: strain-specific receptor epitopes in sialo-sugar chains.

  1992cited by this paper
• Human influenza A virus hemagglutinin distinguishes sialyloligosaccharides in membrane-associated gangliosides as its receptor which mediates the adsorption and fusion processes of virus infection. Specificity for oligosaccharides and sialic acids and the sequence to which sialic acid is attached.

  1986cited by this paper
• Some chemical and analytical aspects of polysaccharide modifications. III. Formation of branched-chain, soluble chitosan derivatives

  1984cited by this paper
• Single amino acid substitutions in influenza haemagglutinin change receptor binding specificity

  1983cited by this paper
• Assay of Sendai Virus by Immunofluorescence and Hemadsorbed Cell-Counting Procedures

  1965cited by this paper

• Fabrication of eco-friendly hydrophobic cellulose paper via paper dip-coating in beeswax for improved barrier characteristics

  2025cites this paper
• Bioactives from Whey: A Sustainable Approach to Enzymatic Production of Sialyl-N-acetyllactosamine

  2022cites this paper
• Antiviral Strategies Using Natural Source-Derived Sulfated Polysaccharides in the Light of the COVID-19 Pandemic and Major Human Pathogenic Viruses

  2021cites this paper
• Tannic acid-functionalized HEPA filter materials for influenza virus capture

  2021cites this paper
• Antiviral effects of human milk oligosaccharides: A review

  2020cites this paper
• Antiviral Polymers: Past Approaches and Future Possibilities

  2020cites this paper
• Advanced Prodrug Strategies in Nucleoside and Non-Nucleoside Antiviral Agents: A Review of the Recent Five Years

  2017cites this paper
• Macromolecular (pro)drugs in antiviral research

  2014cites this paper
• Inhibition of influenza virus infection with chitosan-sialyloligosaccharides ionic complex.

  2014cites this paper
• Capture of influenza viruses and prevention of their infection by coral mineral powder (sango mineral powder).

  2012cites this paper
• Carbohydrate-functionalized chitosan fiber for influenza virus capture.

  2011cites this paper
• Preparation of Glycopolymer-Modified Gold Nanoparticles and a New Approach for a Lateral Flow Assay

  2011cites this paper
• Chemoenzymatic syntheses of sialyl Lewis X–chitosan conjugate as potential anti-inflammatory agent

  2011cites this paper